| Wall Street Journal. Europe 2001 Gautam Naik |
| Title | Subject | Authors |
|---|
| AstraZeneca will handle marketing of cholesterol-lowering drug alone.(Company's profit tops expectations on strong Losec, Nexium sales.) | Business, international | Gautam Naik |
| Bayer may seek ally for drug unit. | Business, international | Neal E. Boudette, Gautam Naik, Anita Raghavan |
| BT is looking for new CEO from outside the company.(Peter Bonfield announces resignation, effective January)(Abstract) | Business, international | Gautam Naik |
| Cell-phone firms face new barrier: fear of towers.(Radiation concerns spark resistance movement.) | Business, international | Gautam Naik |
| Ericsson issues profit warning, prompting sharp sell-off.(Company raises new doubts about turnaround.) | Business, international | Gautam Naik |
| Glaxo's earnings jump 17%, boosted by respiratory drugs. | Business, international | Gautam Naik |
| GlaxoSmithKline pretax profit climbed 19% in first quarter. | Business, international | Gautam Naik |
| Roche's net beat expectations on strong drug sales in half.(Company cites one-time gain, fast growing pharmaceutical business.) | Business, international | Gautam Naik |
| Unilever holds fast to targets, despite 44% drop in net profit.(Statistical Data Included) | Business, international | Gautam Naik |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
